Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
41
GH Quote, Financials, Valuation and Earnings
Last price:
$31.59
Seasonality move
:
10%
Day range:
$30.78 - $31.66
52-week range:
$15.81 - $38.53
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.45x
P/B ratio:
28.68x
Volume:
1M
Avg. volume:
1.8M
1-year change:
7.97%
Market cap:
$3.8B
Revenue:
$563.9M
EPS (TTM):
-$4.24
Analysts' Opinion
-
Consensus RatingGuardant Health has received a consensus rating of Buy. The company's average rating is a Buy based on 14 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $42.30, Guardant Health has an estimated upside of 39.18% from its current price of $31.04.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $32.00 representing 100% downside risk from its current price of $31.04.
Fair Value
-
According to the consensus of 15 analysts, Guardant Health has 39.18% upside to fair value with a price target of $42.30 per share.
GH vs. S&P 500
-
Over the past 5 trading days, Guardant Health has underperformed the S&P 500 by -14.34% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Guardant Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Guardant Health has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Guardant Health reported revenues of $191.5M.
Earnings Growth
-
Guardant Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Guardant Health reported earnings per share of -$0.88.
Enterprise value:
4B
EV / Invested capital:
3.68x
Price / LTM sales:
5.45x
EV / EBIT:
--
EV / Revenue:
5.75x
PEG ratio (5yr expected):
-1.65x
EV / Free cash flow:
-14.50x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$417.5M
Return On Assets:
-30.37%
Net Income Margin (TTM):
-74.02%
Return On Equity:
-651%
Return On Invested Capital:
-42.02%
Operating Margin:
-61.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $430.8M | $535.8M | $692.3M | $143M | $191.5M | |
| Gross Profit | $288.1M | $324.1M | $417.5M | $85.4M | $117M | |
| Operating Income | -$496.5M | -$513.3M | -$515.1M | -$113.5M | -$117.3M | |
| EBITDA | -$552M | -$385.8M | -$467M | -$73.9M | -$96.5M | |
| Diluted EPS | -$5.93 | -$4.06 | -$4.24 | -$0.73 | -$0.88 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.1B | $1.6B | $1.1B | $1.3B | $1.2B | |
| Total Assets | $1.3B | $2.2B | $1.7B | $1.8B | $1.5B | |
| Current Liabilities | $72M | $102.3M | $175.1M | $226.8M | $197.3M | |
| Total Liabilities | $113.5M | $1.5B | $1.5B | $1.6B | $1.6B | |
| Total Equity | $1.1B | $768.8M | $166.7M | $228.3M | -$60.1M | |
| Total Debt | -- | $1.1B | $1.1B | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$295.7M | -$337M | -$254.1M | -$77.8M | -$51.1M | |
| Cash From Investing | -$187.5M | $247.4M | $391.6M | $260.7M | -$294.8M | |
| Cash From Financing | -$187.6M | $389.1M | $92.5M | $3.8M | -$2.9M | |
| Free Cash Flow | -$387.8M | -$363.4M | -$274.4M | -$80.2M | -$55.3M | |
GH
Sector
Market Cap
$3.8B
$45.6M
Price % of 52-Week High
80.56%
45.55%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
7.97%
-31.35%
Beta (5-Year)
1.255
0.772
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$33.29
200-day SMA
Buy
Level
$25.89
Bollinger Bands (100)
Buy
Level
22.47 - 32.55
Chaikin Money Flow
Sell
Level
-14.3M
20-day SMA
Sell
Level
$34.89
Relative Strength Index (RSI14)
Sell
Level
42.86
ADX Line
Sell
Level
19.93
Williams %R
Buy
Level
-93.1592
50-day SMA
Buy
Level
$29.06
MACD (12, 26)
Buy
Level
0.59
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Sell
Level
-74.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.2632)
Sell
CA Score
(Annual)
Level (-3.5991)
Buy
Beneish M-Score
(Annual)
Level (-2.5724)
Buy
Momentum Score
Level (3)
Sell
Ohlson Score
Level (3.3639)
Buy
Piotroski F Score
(Annual)
Level (5)
Sell
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Stock Forecast FAQ
In the current month, GH has received 14 Buy ratings 1 Hold ratings, and 0 Sell ratings. The GH average analyst price target in the past 3 months is $42.30.
-
Where Will Guardant Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Guardant Health share price will rise to $42.30 per share over the next 12 months.
-
What Do Analysts Say About Guardant Health?
Analysts are divided on their view about Guardant Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Guardant Health is a Sell and believe this share price will drop from its current level to $32.00.
-
What Is Guardant Health's Price Target?
The price target for Guardant Health over the next 1-year time period is forecast to be $42.30 according to 15 Wall Street analysts, 14 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is GH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Guardant Health is a Buy. 14 of 15 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GH?
You can purchase shares of Guardant Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Guardant Health shares.
-
What Is The Guardant Health Share Price Today?
Guardant Health was last trading at $31.59 per share. This represents the most recent stock quote for Guardant Health. Yesterday, Guardant Health closed at $31.04 per share.
-
How To Buy Guardant Health Stock Online?
In order to purchase Guardant Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
52
TSLL alert for Dec 24
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
73
PSIX alert for Dec 24
Power Solutions International [PSIX] is up 27.42% over the past day.
Sell
31
SOXL alert for Dec 24
Direxion Daily Semiconductor Bull 3X Shares [SOXL] is up 11.87% over the past day.
